"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
- Clinician Information:
Ketalar Patient Information including How Should I Take
In this Article
- What is ketamine (Ketalar)?
- What are the possible side effects of ketamine (Ketalar)?
- What is the most important information I should know about ketamine (Ketalar)?
- What should I discuss with my health care provider before receiving ketamine (Ketalar)?
- How is ketamine given (Ketalar)?
- What happens if I miss a dose (Ketalar)?
- What happens if I overdose (Ketalar)?
- What should I avoid after receiving ketamine (Ketalar)?
- What other drugs will affect ketamine (Ketalar)?
- Where can I get more information?
What should I discuss with my health care provider before receiving ketamine (Ketalar)?
Before you receive ketamine, tell your doctor if you are allergic to any drugs, or if you have a history of alcoholism.
Ketamine may be harmful to an unborn baby. Before you receive ketamine, tell your doctor if you are pregnant.
How is ketamine given (Ketalar)?
Ketamine is given as an injection through a needle placed into a vein or muscle. You will receive this injection in a clinic or hospital setting.
Your caregivers will monitor your heart function, blood pressure, and breathing while you are under the effects of ketamine.
You may feel strange or slightly confused when you first come out of anesthesia. Tell your caregivers if these feelings are severe or unpleasant.
Additional Ketalar Information
- Ketalar Drug Interactions Center: ketamine inj
- Ketalar Side Effects Center
- Ketalar FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.